We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data.
- Authors
Fagerstedt, Klaus W.; Vesterinen, Tiina; Leijon, Helena; Sihto, Harri; Böhling, Tom; Arola, Johanna
- Abstract
Merkel cell carcinoma (MCC) is a rare, high-grade neuroendocrine neoplasm (NEN) of the skin. Somatostatin receptors (SSTRs) are G protein-linked receptors that regulate cell proliferation and growth. SSTRs are expressed in many NENs; however, scant information is available on their expression in MCCs or their association with clinical parameters and patient outcomes. This retrospective study was conducted at Helsinki University Hospital and the University of Helsinki. Using a tissue microarray, we investigated SSTR1-5 expression by immunohistochemistry in 99 MCC tissue samples. Samples were collected between 1983 and 2017 and coupled with the patients' clinical data. SSTR2-SSTR5 were detected in 69%, 6%, 4%, and 1% of the tumours, respectively. However, SSTR1 expression was not observed. Cytoplasmic SSTR2 positivity was associated with metastatic disease at the time of diagnosis (p = 0.009), but it did not correlate with disease-specificity or overall survival. SSTR2-5 expression was observed in MCCs. In particular, SSTR2 expression is clinically valid because it is associated with metastatic disease at the time of diagnosis and can thus serve as a prognostic marker. Moreover, SSTR2 overexpression provides a molecular basis for tumour imaging and treatment with somatostatin analogues.
- Subjects
IMMUNOHISTOCHEMISTRY; CELL receptors; RETROSPECTIVE studies; GENE expression; SOMATOSTATIN; CELL proliferation; MERKEL cell carcinoma; OVERALL survival
- Publication
Acta Oncologica, 2023, Vol 62, Issue 9, p1001
- ISSN
0284-186X
- Publication type
Article
- DOI
10.1080/0284186X.2023.2239481